| T vs. C | bevacizumab plus carboplatin and paclitaxel | placebo plus SoC | atezolizumab plus bevacizumab plus carboplatin plus paclitaxel | atezolizumab plus SoC |
| bevacizumab plus carboplatin and paclitaxel | --- | NA | NA | NA |
| placebo plus SoC | NA | --- | NA | NA |
| atezolizumab plus bevacizumab plus carboplatin plus paclitaxel | NA | NA | --- | NA |
| atezolizumab plus SoC | NA | NA | NA | --- |
pathologies: 247,249,250
- treatments: 866
result logic
